Heterologous SARS-CoV-2 spike protein booster elicits durable and broad antibody responses against the receptor-binding domain.
Takano T, Sato T, Kotaki R, Moriyama S, Fukushi S, Shinoda M, Kabasawa K, Shimada N, Kousaka M, Adachi Y, Onodera T, Terahara K, Isogawa M, Matsumura T, Shinkai M, Takahashi Y.
Takano T, et al. Among authors: shinoda m.
Nat Commun. 2023 Mar 15;14(1):1451. doi: 10.1038/s41467-023-37128-1.
Nat Commun. 2023.
PMID: 36922492
Free PMC article.